Tech FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss Ars Technica · 10 November 2026 at 15:43 · 5 min read The risk appears small and data is mixed, but FDA wants patients to be aware. Read in Synapse Read on arstechnica.com